Value of plasmodium falciparum histidine-rich protein 2 level and malaria retinopathy in distinguishing cerebral malaria from other acute encephalopathies in Kenyan children

Journal of Infectious Diseases

Volumn 209, Issue 4, 2014, Pages 600-609

  Kariuki, Symon M ^a,d   Gitau, Evelyn ^a,e   Gwer, Samson ^a,b,c   Karanja, Henry K ^a   Chengo, Eddie ^a   Kazungu, Michael ^a   Urban, Britta C ^a,e   Newton, Charles R J C ^a,d,f  

^a Center for Geographic Medicine Research Coast   (Kenya)

^b Kenyatta University   (United States)

^c AFYA RESEARCH AFRICA   (Kenya)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

attributable fractions; cerebral malaria; children; histidine rich protein 2; malaria retinopathy

Indexed keywords

HISTIDINE RICH PROTEIN 2; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ACUTE BRAIN DISEASE; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL FEATURE; COMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; INCIDENCE; KENYAN; MACULAR WHITENING; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALARIA RETINOPATHY; MALE; OPHTHALMOSCOPY; PAPILLEDEMA; PARASITEMIA; PERIPHERAL WHITENING; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETINA HEMORRHAGE; RETINA MACULOPATHY; RETINOPATHY; SENSITIVITY AND SPECIFICITY;

ATTRIBUTABLE FRACTIONS; CEREBRAL MALARIA; CHILDREN; HISTIDINE-RICH PROTEIN-2; MALARIA RETINOPATHY;

ANTIGENS, PROTOZOAN; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; INFANT; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALE; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; RETINAL DISEASES;

EID: 84893340214     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit500     Document Type: Article

References (34)

1. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4:827-40.
2. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94:S1-90.
3. Mwangi TW, Ross A, Snow RW, Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 2005; 191:1932-9.
4. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4.
5. Reyburn H, Mbatia R, Drakeley C, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004; 329:1212.
6. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. NatMed 2004; 10:143-5.
7. Lewallen S, Bakker H, Taylor TE, et al. Retinal findings predictive of outcome in cerebral malaria. Trans R Soc Trop Med and Hyg 1996; 90:144-6.
8. Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005; 206:319-48.
9. Manning L, Laman M, Stanisic D, et al. Plasma Plasmodium falciparum histidine-rich protein-2 concentrations do not reflect severity of malaria in Papua New Guinean children. Clin Infect Dis 2011; 52:440-6.
10. Rubach MP, Mukemba J, Florence S, et al. Plasmodium falciparum Histidine-Rich Protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One 2012; 7:e35985.
11. Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005; 2:e204.
12. Hendriksen IC, White LJ, Veenemans J, et al. Defining falciparummalaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis 2013; 207:351-61.
13. Hendriksen ICE, Mwanga-Amumpaire J, von Seidlein L, et al. Diagnosing severe falciparum malaria in parasitaemic african children: a prospective evaluation of plasma PfHRP2 measurement. PLoS Med 2012; 9:e1001297.
14. Seydel KB, Fox LL, Glover SJ, et al. Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis 2012; 206:309-18.
15. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-35.
16. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994; 13: 2345-58.
17. Bejon P, Berkley JA, Mwangi T, et al. Defining childhood severe falciparum malaria for intervention studies. PLoS Med 2007; 4:e251.
18. Kariuki SM, Ikumi M, Ojal J, et al. Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast. Brain 2011; 134:1519-28.
19. Scott JAG, Bauni E, Moisi JC, et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol 2012; 41:650-7.
20. O'MearaWP, Bejon P, Mwangi TW, et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008; 372: 1555-62.
21. Taylor T, Olola C, Valim C, et al. Standardized data collection for multi-centre clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg 2006; 100: 615-22.
22. Molyneux ME, Taylor TE,Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71:441-59.
23. Newton CR, Chokwe T, Schellenberg JA, et al. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 161-5.
24. Beare NAV, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial retinopathy: A newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006; 75:790-7.
25. Idro R, Bitarakwate E, Tumwesigire S, John CC. Clinical manifestations of severe malaria in the highlands of southwest Uganda. Am J Trop Med Hyg 2005; 72:561-7.
26. Rogers WO, Atuguba F, Oduro AR, Hodgson A, Koram KA. Clinical case definitions and malaria vaccine efficacy. J Infect Dis 2006; 193: 467-73.
27. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006; 28:51-60.
28. Birbeck GL, Beare N, Lewallen S, et al. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: Findings from a prospective cohort study. Am J Trop Med Hyg 2010; 82:231-4.
29. Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR. Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol 2002; 119:839-47.
30. Schémann JFO, Doumbo O, Malvy D, et al. Ocular lesions associated with malaria in children in Mali. Am J Trop Med Hyg 2002; 67:61-3.
31. Newton CR,Winstanley PA, Marsh K. Retinal haemorrhages in falciparum malaria. Arch Dis Child 1991; 66:753.
32. Beare NA, Southern C, Lochhead J, Molyneux ME, Lewallen S, Harding SP. Inter-observer concordance in grading retinopathy in cerebral malaria. Ann Trop Med Parasitol 2002; 96:105-8.
33. Essuman VA, Ntim-Amponsah CT, Astrup BS, et al. Retinopathy in severe malaria in Ghanaian children-overlap between fundus changes in cerebral and non-cerebral malaria. Malar J 2010; 9:232.
34. Dondorp AM, Fanello CI, Hendriksen ICE, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647-57.